| Evaluation | Validation |  |  | Effect Size |
---|---|---|---|---|---|
Sample | 3593 | 3594 | Â | Â | Â |
Continuous | Mean (sd) | Mean (sd) | t (7185) | p | Cohen's d |
Age | 39.49 (12.21) | 39.43 (12.27) | 0.048 | 0.962 | 0.005 |
PANSS | Â | Â | Â | Â | Â |
   Positive | 19.43 (6.60) | 19.57 (6.80) | - 0.961 | 0.373 | - 0.021 |
   Negative | 22.70 (6.92) | 22.71 (6.93) | - 0.049 | 0.961 | - 0.001 |
   General | 40.82 (10.09) | 40.85 (10.14) | - 0.142 | 0.887 | - 0.003 |
   Total Score | 82.95 (19.30) | 83.13 (19.60) | - 0.471 | 0.638 | - 0.009 |
Categorical | n (Percent) | n (Percent) | Chi Square | Â | Â |
Gender |  |  |  |  | Cramer'sφ |
   Male | 2391 (66.55%) | 2383 (66.30%) | Χ 2 (1) = 1.40 | 0.595 | 0.014 |
   Female | 1202 (33.45%) | 1210 (33.67%) |  |  |  |
Diagnosis | Â | Â | Â | Â | Â |
   Schizophrenia | 3437 (95.66%) | 3429 (95.41%) | Χ 2 (1) = 1.04 | 0.669 | 0.012 |
   Schizoaffective | 156 (4.34%) | 165 (4.59%) |  |  |  |
Race | Â | Â | Â | Â | Â |
   Caucasian | 2407 (66.99%) | 2432 (67.67%) | Χ 2 (4) = 13.70 | 0.134 | 0.044 |
   Asian | 255 (7.10%) | 246 (6.84%) |  |  |  |
   Black | 614 (17.09%) | 648 (18.03%) |  |  |  |
   Hispanic | 187 (5.20%) | 177 (4.92%) |  |  |  |
   Other | 130 (3.62%) | 91 (2.53%) |  |  |  |